Cohance Lifesciences Limited
COHANCE

Cohance Lifesciences Limited

Pharmaceuticals
Share price
463
Market cap
₹17,699 Cr
1Y return
48%

A Hyderabad-based contract development and manufacturing organization serving leading global pharmaceutical and fine chemical companies. Cohance Life provides integrated services spanning process research and development through late-stage clinical and commercial manufacturing for new chemical entities. The company distinguishes itself through its commitment to delivering customized solutions that fulfill specific customer needs and expectations across the entire drug development lifecycle.

Investors holding Cohance Lifesciences Limited

HDFC Mutual Fund
HDFC Mutual Fund
Mutual Fund
2.16%
1.75%

Latest move

DSP Mutual FundDecreased
DSP Mutual Fund reduced its stake in Cohance Lifesciences from 4.29% to 3.53% by selling 28,99,996 shares in an open market transaction on August 7, 2026.
7 Aug 2026Sign in to read more

Whales made 6 more moves in Cohance Lifesciences Limited

Sign in to see who is buying and selling.

Sign in to find out
Cohance Lifesciences — investor holdings · WhaleWatch